Caffeine - An atypical drug of dependence

Drug and Alcohol Dependence

Volumn 51, Issue 1-2, 1998, Pages 199-206

  Daly, John W ^a   Fredholm, Bertil B ^b  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE RECEPTOR; ALCOHOL; CAFFEINE;

BEHAVIOR; DENDRITIC SPINE; DISCRIMINATIVE STIMULUS; DRUG ABUSE; DRUG DEPENDENCE; DRUG EFFECT; DRUG TOLERANCE; HUMAN; MOOD; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PSYCHOMOTOR ACTIVITY; RECEPTOR UPREGULATION; REVIEW; SLEEP;

EID: 0032104572     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0376-8716(98)00077-5     Document Type: Article

References (63)

1. Brockwell, N.T., Eikelboom, R., Beninger, R.J., 1991. Caffeine-induced place and taste conditioning: production of dose-dependent preference and aversion. Pharmacol. Biochem. Behav. 38, 513-517.
2. Budney, A.J., Higgins, S.T., Hughes, J.R., Bickel, W.K., 1993. Nicotine and caffeine use in cocaine-dependent individuals. J. Subst. Abuse 5, 117-130.
3. 1 receptors. J. Pharmacol. Exp. Ther. 273, 637-642.
4. Daly, J.W., 1993. Mechanism of action of caffeine. In: Garattini, S. (Ed.), Caffeine, Coffee and Health. Raven Press, New York, pp. 97-150.
5. Dar, M.S., 1990. Central adenosinergic system involvement in ethanol-induced motor incoordination in mice. J. Pharmacol. Exp. Ther. 255, 1202-1209.
6. 2A receptor in the rat striatum. J. Neurochem. 69, 315-321.
7. 2 receptors in rat striatal membranes. Proc. Natl. Acad. Sci. U.S.A. 88, 7238-7241.
8. Ferré, S., Fuxe, K., von Euler, G., Johansson, B., Fredholm, B.B., 1992. Adenosine-dopamine interactions in the brain. Neuroscience 51, 501-512.
9. 1 receptor-mediated mechanisms. Eur. J. Neurosci. 8, 1545-1553.
10. 1 receptor antagonist binding sites. Neurosci. Lett. 208, 109-112.
11. Ferré, S., Fredholm, B.B., Morelli, M., Popoli, P., Fuxe, K., 1997. Adenosine-dopamine receptor-receptor interactions in the basal ganglia. Trends Neurosci. 20, 482-486.
12. Fredholm, B.B., Dunwiddie, T.V., 1988. How does adenosine inhibit transmitter release? Trends Pharmacol. Sci. 9, 130-134.
13. 2A receptors and the actions of caffeine. In: Okada, Y. (Ed.), The Role of Adenosine in the Nervous System, Elsevier Science, Amsterdam, pp. 51-74.
14. 2 receptor agonists but not to their synergistic interaction. Eur. J. Pharmacol. 262, 65-75.
15. 2 dopamine receptor antagonists block caffeine-induced stimulation of locomotor activity in rats. Pharmacol. Biochem. Behav. 47, 89-94.
16. Garrett, B.E., Holtzman, S.G., 1995. Does adenosine receptor blockade mediate caffeine-induced rotational behavior? J. Pharmacol. Exp. Ther. 274, 207-214.
17. Garrett, B.E., Griffiths, R.R., 1997. The role of dopamine in the behavioral effects of caffeine in animals and humans. Pharmacol. Biochem. Behav. 57, 533-541.
18. Gilliland, K., Bullock, W., 1984. Caffeine: a potential drug of abuse. Adv. Alcohol Subst. Abuse 3, 53-73.
19. Griffiths, R.R., Mumford, G.K., 1995. Caffeine - a drug of abuse? In: Bloom, F.E., Kupfer, D.J. (Eds.), Psychopharmacology: The Fourth Generation of Progress. Raven Press, New York, pp. 1699-1713.
20. Griffiths, R.R., Mumford, G.K., 1996. Caffeine reinforcement, discrimination, tolerance and physical dependence in laboratory animals and humans. In: Schuster, C.R., Kuhar, M.J. (Eds.), Handbook of Experimental Pharmacology. Springer-Verlag, Heidelberg, pp. 315-341.
21. Griffiths, R.R., Woodson, P.P., 1988. Reinforcing properties of caffeine: studies in humans and laboratory animals. Pharmacol. Biochem. Behav. 29, 419-427.
22. 1 and NMDA receptors promotes presynaptic inhibition in the rat nucleus accumbens via adenosine release. J. Neurosci. 17, 5271-5280.
23. Holtzman, S.G., 1990. Caffeine as a model drug of abuse. Trends Pharmacol. Sci. 11, 355-356.
24. Holtzman, S.G., Finn, I.B., 1988. Tolerance to behavioral effects of caffeine in rats. Pharmacol. Biochem. Behav. 29, 411-418.
25. Holtzman, S.G., Mante, S., Minneman, K.P., 1991. Role of adenosine receptors in caffeine tolerance. J. Pharmacol. Exp. Ther. 256, 62-68.
26. Horger, B.A., Wellman, P.J., Morien, A., Davies, B.T., Schenk, S., 1991. Caffeine exposure sensitizes rats to the reinforcing effects of cocaine. Neuroreport 2, 53-56.
27. Howell, L.L., Landrum, A.M., 1997. Effects of chronic caffeine administration on respiration and schedule-controlled behavior in rhesus monkeys. J. Pharmacol. Exp. Ther. 283, 190-199.
28. Istvan, J., Matarazzo, J.D., 1984. Tobacco, alcohol, and caffeine use: a review of their interrelationships. Psychol. Bull. 95, 301-326.
29. Jacobson, K.A., von Lubitz, D.K., Daly, J.W., Fredholm, B.B., 1996. Adenosine receptor ligands: differences with acute versus chronic treatment. Trends Pharmacol. Sci. 17, 108-113.
30. James, J.E., 1991. Caffeine and Health, Academic Press, New York.
31. 2 receptor activation on electrically evoked dopamine and acetylcholine release from rat striatal slices. J. Pharmacol. Exp. Ther. 267, 801-808.
32. 1 receptor binding and mRNA levels in rat brain. Naunyn-Schmiedeberg's Arch. Pharmacol. 347, 407-414.
33. Johansson, B., Lindström, K., Fredholm, B.B., 1994. Differences in the regional and cellular localization of c-fos messenger RNA induced by amphetamine, cocaine and caffeine in the rat. Neuroscience 59, 837-849.
34. Klotz, K.-N., Hessling, J., Hegler, J., et al., 1997. Comparative pharmacology of human adenosine receptor subtypes - characterization of stably transfected receptors in CHO cells. Naunyn-Schmiedeberg's Arch. Pharmacol. 357, 1-9.
35. Lau, C.E., Falk, J.L., 1994. Tolerance to oral and IP caffeine: locomotor activity and pharmacokinetics. Pharmacol. Biochem. Behav. 48, 337-344.
36. 2a receptor. Nature 388, 674-678.
37. Lekka, N.P., Paschalis, C., Beratis, S., 1997. Nicotine, caffeine and alcohol use in high-and low-dose benzodiazepine users. Drug Alcohol Depend. 45, 207-212.
38. 1 receptor-mediated effects on c-fos expression. J. Neurosci. 17, 8038-8048.
39. 2 receptor interaction in globus pallidus. Synapse 22, 132-138.
40. 2A receptors in regulating GABAergic synaptic transmission in striatal medium spiny neurons. J. Neurosci. 15, 605-611.
41. Morton, R.A., Davies, C.H., 1997. Regulation of muscarinic acetylcholine receptor-mediated synaptic responses by adenosine in the rat hippocampus. J. Physiol. London 502, 75-90.
42. Mumford, G.K., Holtzman, G.K., 1991. Qualitative differences in the discrimination stimulus effects of low and high doses of caffeine in the rat. J. Pharmacol. Exp. Ther. 258, 857-865.
43. Mumford, G.K., Evans, S.M., Kaminski, B.J., et al., 1994. Discriminative stimulus and subjective effects of theobromine and caffeine in humans. Psychopharmacology 115, 1-8.
44. Nehlig, A., 1994. Caffeine, brain energy metabolism and blood flow: a basis for the understanding of the behavioral effects of the methylxanthines. Pharmacopsychoecologia 7, 97-107.
45. 2-selective agonists and antagonists: evidence for synergism and antagonism. J. Pharmacol. Exp. Ther. 259, 286-294.
46. Nikodijević, O., Jacobson, K.A., Daly, J.W., 1993. Locomotor activity in mice during chronic treatment with caffeine and withdrawal. Pharmacol. Biochem. Behav. 44, 199-216.
47. 2A receptors. Trends Pharmacol. Sci. 17, 364-372.
48. 2a receptors in rat striatum: implications for the mechanism and treatment of tardive dyskinesia. J. Neurochem. 65, 2057-2064.
49. 1 receptor stimulation in rodents. Neurosci. Lett. 218, 209-213.
50. Rainnie, D.G., Grunze, H.C.R., McCarley, R.W., Greene, R.W., 1994. Adenosine inhibition of mesopontine cholinergic neurons: implications for EEG arousal. Science 263, 689-692.
51. 2A receptor antagonists as new agents for the treatment of Parkinson's disease. Trends Pharmacol. Sci. 18, 338-344.
52. 1 adenosine receptors in rat brain with emphasis on localization in the hippocampal formation, cerebral cortex, cerebellum and basal ganglia. Brain Res. 677, 193-203.
53. 2A receptor immunoreactivity in rat striatum. Soc. Neurosci. Abstr. 23, 1494.
54. Schuh, K.J., Griffiths, R.R., 1997. Caffeine reinforcement: the role of withdrawal. Psychopharmacology 130, 320-326.
55. A receptors and L-type calcium channels in mouse brain. Cell. Mol. Neurobiol. 13, 247-261.
56. Shi, D., Nikodijevic, O., Jacobson, K.A., Daly, J.W., 1994. Effects of chronic caffeine on adenosine, dopamine and acetylcholine systems in mice. Arch. Pharmacodyn. Ther. 328, 261-287.
57. 3 receptor agonist on the expression of immediate early genes in globus pallidus. Neuropharmacology 36, 1009-1317.
58. Svenningsson, P., Nomikos, G.G., Fredholm, B.B., 1995. Biphasic changes in locomotor behavior and in expression of mRNA for NGFI-A and NGFI-B in rat striatum following acute caffeine administration. J. Neurosci. 15, 7612-7624.
59. Svenningsson, P., Johansson, B., Fredholm, B.B., 1996. Caffeine-induced expression of c-fos mRNA and NGFI-A mRNA in caudate-putamen and in nucleus accumbens are differentially affected by the N-methyl-D-aspartate receptor antagonist MK-801. Mol. Brain Res. 35, 183-189.
60. 2A receptor messenger RNA in the rat central nervous system with special reference to dopamine innervated areas. Neuroscience 80, 1171-1185.
61. 2A receptors underlies the behavioral activating effect of caffeine and is associated with reduced expression of messenger RNA for NGFI-A and NGFI-B in caudate-putamen and nucleus accumbens. Neuroscience 79, 753-764.
62. Swanson, J.A., Lee, J.W., Hopp, J.W., 1994. Caffeine and nicotine: a review of their joint use and possible interactive effects in tobacco withdrawal. Addict. Behav. 19, 229-256.
63. Worley, C.M., Valadez, A., Schenk, S., 1994. Reinstatement of extinguished cocaine-taking behavior by cocaine and caffeine. Pharmacol. Biochem. Behav. 48, 217-221.